Nurix Therapeutics, Inc. NRIX Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s short- and long-term operating lease liabilities?
- Nurix Therapeutics, Inc. (NRIX) reported short- and long-term operating lease liabilities of $205K in Q4 2025.
- How has Nurix Therapeutics, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
- Nurix Therapeutics, Inc.'s short- and long-term operating lease liabilities increased by 112.2% year-over-year, from -$1.68M to $205K.
- What is the long-term trend for Nurix Therapeutics, Inc.'s short- and long-term operating lease liabilities?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s short- and long-term operating lease liabilities has grown at a -0.4% compound annual growth rate (CAGR), from -$5.14M to -$5.07M.